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ABSTRACT
Objectives: To assess the impact of pelvic magnetic resonance imaging (MRI) findings in the indication for uterine-artery 
embolization in women with fibroids, as well as the correlation between MRI and ultrasound (US) examinations for diag-
nosing adenomyosis. 
Material and methods: A retrospective observational study was performed through the analysis of the medical records 
of 263 women referred for uterine-artery embolization as treatment for fibroids after undergoing US and MRI examina-
tions. To compare uterine volume and fibroid measurement in US and MRI, the Wilcoxon test was used; for the number 
of fibroids, the McNemar test was used. The kappa coefficient was used to evaluate the correlation between US and MRI 
findings for diagnosing adenomyosis. 
Results: The mean age of patients was 37.9 ± 6.8 years and 191 (72.6%) were nulliparous. Forty-three patients with adeno-
myosis associated with fibroid were diagnosed by MRI; US indicated the presence of adenomyosis in 12 (4.56%) women. 
There was agreement between MRI and US in the diagnosis of adenomyosis in 218/263 (82.9%) patients (p < 0.05). In the US 
examination, the mean uterine volume was lower (389 ± 340.8 cm³) than that observed in MRI (472.2 ± 415.9 cm³; p < 0.001). 
Regarding the number of fibroids, MRI showed a greater number of patients with multiple fibroids (68.8% vs. 57.4%, MRI 
and US, respectively; p < 0.001). 
Conclusions: In women with fibroids referred for uterine-artery embolization, MRI findings led to the revision of the initial 
diagnosis in 17.1% cases. US showed a lower sensitivity for diagnosing adenomyosis than MRI.
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INTRODUCTION
Uterine fibroids (myoma) are the most common tumor 
in the female genital tract, with an estimated incidence of 
20–40% among women of reproductive age, and higher 
incidence in Black women compared with Caucasians [1]. 
Although fibroids are often asymptomatic, they can cause 
various symptoms such as abnormal uterine bleeding, a feel-
ing of heaviness in the lower abdomen, urinary incontinence 
or retention, and lower abdominal pain [2, 3]. Hysterec-
tomy is considered the definitive treatment and may be 
performed vaginally, abdominally, or laparoscopically [4]. 
The need to preserve the uterus and appendages led to 
the development of less-invasive techniques such as my-
omectomy [5], which was the standard treatment until the 
uterine-artery embolization technique was developed [3]. 
The basic principle of embolization is selective catheteri-
zation of the uterine arteries and occlusion of the distal 
arteries which feed the fibroids, causing tumor infarction 
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with preservation of the uterus [2, 6]. The other options 
for the uterine myoma treatment are the following: mag-
netic resonance-guided high-intensity focused ultrasound 
(MRgFUS), transvaginal route for radiofrequency ablation, 
and robotic laparoscopic myomectomy. MRgFUS is com-
parable to uterine-artery embolization, and appears to be 
a cost effective treatment option, especially in older women. 
Transvaginal route for radiofrequency ablation is a promis-
ing new nonsurgical alternative, which needs to be studied 
in larger trials to establish its safety and efficacy. Robotic 
laparoscopic myomectomy is comparable to traditional 
laparoscopic technique in short surgical outcomes but is 
associated with higher costs [7].
Ultrasound (US) is considered the examination of choice 
for the initial diagnosis and monitoring of uterine fibroids [8]. 
But because of its multiplanar capacity, excellent tissue 
contrast, and reproducibility, magnetic resonance imag-
ing (MRI) has become the investigation of choice in cases 
requiring further investigation [3]. One study showed that 
when the indication for imaging investigations is to define 
the best therapeutic strategy, especially in cases selected 
for uterine-artery embolization, information provided from 
US imaging is insufficient and may lead to therapeutic errors 
in up to 25% cases [9].
OBJECTIVES
The aim of this study was to assess the impact of pelvic 
MRI findings in the indication for uterine-artery emboli-
zation in women with fibroids, as well as the agreement 
between MRI and US examinations for diagnosing adeno-
myosis.
MATERIAL AND METHODS
This retrospective observational study analyzed the 
medical records of women referred for uterine-artery em-
bolization to treat fibroids between January 2000 and April 
2015, who had undergone US and MRI examinations and 
for whom medical history was available. The US examina-
tions were performed at several imaging clinics in the city 
of Recife, Pernambuco, Brazil, and MRI were performed at 
a single reference center in interventional radiology. Inclu-
sion criteria were aged > 18 years, and interval of up to 
12 months between US and MRI examinations. The exclusion 
criterion was incomplete medical records. This study was 
approved by the Ethics Committee of the Federal University 
of Pernambuco (UFPE); the need for an informed consent 
was waived because this study was retrospective in nature.
The US examinations were performed using an intracavi-
tary transducer and supplemented by a transabdominal US in 
cases of bulky uterus. All reports contained information on the 
appendages and endometrium. For the fibroids, the number, 
location relative to the myometrium and/or endometrium, 
and measurements of the largest fibroid were obtained. Uter-
ine volume was measured in cm³, and was calculated using 
the following formula: longitudinal × transverse × anteropos-
terior × 0.52. US criteria of adenomyosis were the following: 
(1) uterus enlarged, (2) heterogeneous myometrium with 
hipoecoic areas, (3) thickening or abnormality of the suben-
dometrial myometrium, (4) linear grooves from endometrium 
to myometrium, (5) subendometrial retention cysts with vari-
able format or dimension, and (6) asymmetry of uterine wall 
with predominance of the posterior wall.
The MRI examinations were performed by a single radi-
ologist using a Magnetom Aera 1.5 Atim device (Siemens AG, 
Erlangen, Germany). The following sequences were initially 
obtained: T1 showing the edge and the internal anatomy of 
the organs, and T1 with fat saturation. Next, a MRI contrast 
agent (gadolinium — diethylene triamine pentaacetic acid) 
was injected. A new T1 sequence with fat saturation was 
then performed to distinguish the layers of the uterus and 
the cancer stages, if present, as well as a T2 sequence to 
differentiate the uterine layers and permit diagnosis of any 
abnormalities (Fig. 1). Sagittal, axial and coronal sections of 
the uterus were obtained, regarding the endometrial cav-
ity. To diagnose adenomyosis, the junctional zone borders 
were evaluated for uniformity and thickness. Thickness was 
measured in the anterior and posterior walls at the thickest 
portion. A diagnosis of adenomyosis was made when the 
junctional zone was not uniform, in the presence of poorly 
delimited focal areas in the myometrium, and when the 
thickness of the junctional zone was ≥ 12 mm [10, 11] (Fig. 2). 
The following data from the clinical history were analyzed: 
age, parity, desire to have children in the future, previous 
treatment, and current symptoms.
The indications for uterine-artery embolization were 
as follows: (1) vascularized fibroid, (2) unsuccessful surgical 
approach to treat the fibroid, (3) fibroid associated with 
adenomyosis, and (4) intramural fibroid of > 5 cm. The con-
traindications were as follows: (1) non-vascular degenerated 
fibroids, (2) subserosal or submucosal fibroid with pedicle, 
(3) absence of fibroid, and (4) presence of adenomyosis not 
associated with fibroids.
The data were transferred into an Excel 2007 spread-
sheet (Microsoft Corp., Redmond, WA, USA) and analyzed 
using the Statistical Package for the Social Sciences software 
(SPSS) version 20.0 for Windows (SPSS Inc., Chicago, IL, USA). 
For the quantitative variables (age, uterine volume, number 
of fibroids, size of fibroids), data were expressed as means, 
medians, standard deviations, minimum, and maximum. 
For qualitative variables (parity, desire to have children in 
the future), data were expressed as percentages (%). For the 
comparison between uterine volume and the extent of fibroid 
between US and MRI findings, the Wilcoxon test was used; 
for the number of fibroids, the McNemar test was applied. To 
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assess the correlation between US and MRI findings in the di-
agnosis of adenomyosis, the kappa coefficient was used, and 
classified as follows: poor, 0.00–0.20; fair, 0.20–0.40, moderate, 
0.40–0.60; good, 0.60–0.80; and very good, 0.80–1.00. In all 
analyses, a significance level of (p) of < 0.05 was adopted.
RESULTS
The study included 263 patients with fibroids, mean age 
37.9 ± 6.8 years (range 18–58 years). As for parity, 191 (72.6%) 
were nulliparous; 41 (15.6%) primiparous; and 31 (25.1%) 
multiparous. Of this sample group, 149 (56.7%) reported 
the desire to have children. One hundred and twenty two 
patients referred previous treatment for uterine myoma: 
hormonal 94/122 (77.0%), hysteroscopy 27/122 (22.1%), lap-
aroscopy 14/122 (11.5%), and laparotomy 28/122 (23.0%). 
None of these patients had indication to hysterectomy 
treatment.
A total of 43 patients with adenomyosis associated 
with fibroids were diagnosed by MRI, with a mean age of 
37.9 ± 6.8 years (range 22–58 years); of these, 84% were 
aged > 35 years. As for parity, 25/43 (58%) were nullipa-
rous; 8/43 (18.6%) primiparous, and 10/43 (23%) multip-
arous. The desire to have children in the future was re-
ported by 15/43 (34.9%) of these women, 13/15 (86.6%) 
of whom were nulliparous. The presence of symptoms 
was observed in 42/43 (97.7%) women: uterine bleeding 
in 31/42 (73.8%), lower abdominal pain in 6/42 (14.3%), 
sensation of increased abdominal volume in 2/42 (4.7%), 
increased urinary frequency in 1/42 (2.4%), and difficulty 
conceiving in 2/42 (4.7%).
In US imaging, mean uterine volume was lower 
(389 ± 340.8 cm³) than the volume observed in MRI 
(472.2 ± 415.9 cm³; p < 0.001). The mean size of the larg-
est fibroid was statistically similar between the two meth-
ods. Regarding the number of fibroids, MRI showed a greater 
number of women with multiple fibroids (68.8% vs. 57.4%, 
MRI and US, respectively, p < 0.001) (Tab. 1).
Of the 263 evaluated patients, 216 (82.1%) had an in-
dication for uterine-artery embolization according to their 
clinical data and US. After MRI, the indication was altered 
for 51 (19.3%) patients. Of the 216 patients initially indi-
cated for embolization, 33 (15.3%) were contraindicated 
by MRI results; of the 47 that were contraindicated by US, 
MRI showed indication in 18 (38.3%). According to Table 2, 
Figure 1.A. Transvaginal ultrasound, sagittal plane, showing uterine fibroid (blue arrow); B. Magnetic resonance imaging, sagittal plane,  
T1 showing uterine fibroid (blue arrow)
A B
Figure 2. MRI of the pelvis in the sagittal plane, T1 showing a uterus with 
adenomyosis with loss of definition of the junctional zone (blue arrow)
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there was a statistically significant agreement between the 
two methods (p < 0.001), with a calculated kappa of 0.41.
Of the 263 analyzed medical records, in 12 (4.56%) 
women adenomyosis was observed in US. After evaluating 
MRI imaging, this diagnosis was ruled out in 7/12 cases. In 
addition to the five cases previously diagnosed by US, MRI 
examination showed adenomyosis in 38 other women, total-
ing 43/263 (16.35%) cases. Table 3 shows the analysis of the 
agreement between US and MRI findings in the diagnosis of 
adenomyosis. As can be seen in the table, in 218/263 (82.9%) 
of patients there was agreement between MRI and US find-
ings for diagnosing adenomyosis, and adenomyosis classi-
fication differed in 45 (17.1%) of the women. We observed 
that the US diagnosed adenomyosis in seven women who 
were not diagnosed on MRI imaging. In view of these data, 
there was a statistically significant correlation between the 
two methods (p < 0.05), but the calculated kappa was very 
low (< 0.2).
DISCUSSION
In this study, the authors evaluated the experience of 
this service in analyzing 263 women who underwent uter-
ine-artery embolization because of fibroids. The mean age 
of the women in the present study was lower than that ob-
served by Laios et al. [12] (43.3 years) and by Rajan et al. [9] 
(43.4 years), who evaluated 118 and 180 women, respec-
tively. In the present study, uterine volume was significantly 
higher in MRI than in US. This result was also observed 
by Stoelinga et al. [13], who assessed 83 women who un-
derwent uterine-artery embolization because of fibroids, 
and observed a mean uterine volume 557 cm3 in MRI and 
472 cm3 in US. Likewise, Rajan et al. [9] observed a mean vol-
ume of 701 cm3 in MRI and 658 cm3 in US. As for the number 
of fibroids, MRI showed a greater number of women with 
multiple fibroids. In a study conducted by Malartic et al. [2], 
US showed more than five fibroids in 12 women (12/68, 
17.6%), whereas MRI showed more than five fibroids in 
31 women (31/68; 45.6%). It is not consensus in the literature 
regarding the importance of uterine volume and number 
of myomas as success factors for uterine artery emboliza-
tion. Toor et al. [14] assessed 78 patients who underwent 
uterine-artery embolization to investigate the MRI findings 
associated with clinical failure. The reduction in uterine and 
dominant fibroid volumes was greater in the success group 
compared with the failure group; however, the difference 
was not statistically significant. The reduction in total fibroid 
Table 1. Sonographic and magnetic resonance imaging data of women with adenomyosis referred for uterine-artery embolization
Characteristic Ultrasound Magnetic resonance imaging p
Uterine volume [cm3]
Mean (SD) 289.2 (211.9) 334.9 (220.4)
0.0491Median (25th–75th) 236.8 (118.4–412.9) 297.0 (173.0–445.3)
Minimum-maximum 58.6–916 76.0–1.029
Number of fibroids
1 or 2 fibroids 19 (44.2%) 11 (25.6%)
0.0212
 ultiple 24 (55.8%) 32 (74.4%)
Largest fibroid [cm]
Mean (SD) 5.4 (2.7) 5.2 (2.6)
0.2061Median (25th–75th) 5.1 (3.5–7.8) 4.5 (3.2–6.9)
Minimum-maximum 0.8–11.4 1.0–11
1Wilcoxon’s test; 2McNemar test; SD — standard deviation
Table 2. Analysis of agreement in the indication for uterine-artery 
embolization between clinical/ultrasound and pelvic MRI findings 
in women with fibroids
Indication
Clinical/ultrasound
MRI indication
No (n = 62) Yes (n = 201)
No 29 (46.8%) 18 (9.0%)
Yes 33 (53.2%) 183 (91.0%)
Kappa = 0.413 (p < 0.001); MRI — magnetic resonance imaging
Table 3. Agreement between ultrasound and magnetic resonance 
imaging for diagnosing adenomyosis in women referred for uterine-
-artery embolization
Diagnostic, ultrasound
Diagnostic, magnetic resonance 
imaging
No (n = 220) Yes (n = 43)
No 213 (96.8%) 38 (88.4%)
Yes 7 (3.2%) 5 (11.6%)
Kappa = 0.119 (p = 0.015); Sensitivity = 11.63% (US vs. MRI); 
Sensitivity = 96.82% (US vs. MRI); Accuracy = 82.9% (percentage of concordant 
pairs between the two methods); MRI = considered the gold standard
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volume was greater in the success group than the failure 
group 48.2% vs. 33.8%, respectively.
In the present study, MRI altered the indication for uter-
ine-artery embolization in 51/263 (19.4%) cases, a result 
similar to that reported by Rajan et al. [9], who observed 
that the indication was altered in 14/116 (12.1%) women 
because US did not correctly quantify/locate the fibroids. In 
the present study, adenomyosis was associated with fibroids 
in 43/263 (16.35%) cases. The diagnosis of adenomyosis as-
sociated with fibroids is important for counseling women 
that the results of uterine-artery embolization, as well as 
the resolution of symptoms, may not be as long-lasting 
compared with the results obtained when the diagnosis is 
fibroid alone [15]. Of the 43 patients in the present study 
who were diagnosed with adenomyosis by MRI, only one 
did not have symptoms. In symptomatic cases, bleeding was 
present in 84% women aged > 35 years. Bleeding is the main 
symptom, present in approximately 40–60% women [16].
Although US is the method of choice for diagnosing 
gynecological pelvic pathologies because of its low cost 
and greater accessibility, its sensitivity for diagnosing ad-
enomyosis is low. In the present study, US had a sensitivity 
of 11.63% and specificity of 96.82%, compared with MRI. In 
the study by Malartic et al. [2], US showed lower sensitivity 
(5.5%) and similar specificity (98.3%). However, in a system-
atic review Champaneria et al. [17] observed that US and 
MRI showed high and similar sensitivities (72% vs. 77%, 
respectively) for diagnosing adenomyosis. Nonetheless, in 
the case of adenomyosis diagnosis using US is influenced 
by the examiner’s experience, type of equipment, and an-
atomical presentation of the uterus; technical advances 
such as three-dimensional US can be an important tool 
in infertile women with adenomyosis [17]. In the present 
study, the authors believe that the low sensitivity of US 
resulted least partially from the fact that this examination 
was conducted in various imaging clinics with different 
examiners and equipments, however all examiners were 
board of Brazilian College of Radiology or Brazilian Federa-
tion of Gynecology and Obstetrics and the US equipments 
were high definition.
CONCLUSIONS
In summary, MRI was shown to be a better preopera-
tive evaluation method for uterine-artery embolization be-
cause it modified the initial US diagnosis in 17.1% cases. US 
showed low sensitivity for diagnosing adenomyosis associ-
ated with fibroids in comparison with MRI.
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